On September 11, Aehr Test rose 8.73% in regular trading, trading around $101.575/share, with turnover of approximately $86.66 million. The rally was driven by Oppenheimer initiating coverage on the company with an Outperform rating and a $120 price target, citing an AI-driven business inflection point.

Oppenheimer projects fiscal Q2 2027 revenue of $43.7 million, well above the $37 million consensus estimate, with H1 revenue expected at $70.9 million versus the Street's $63 million forecast, supported by strong Sonoma platform backlog. The firm highlighted that rising chip power and package value increase the cost of late failures, bolstering demand for Aehr's burn-in testing solutions. The company's package-level platform Sonoma is ramping with a leading hyperscaler through a record $41 million order, while its FOX-XP wafer-level platform recently entered high-volume manufacturing with a major AI processor customer, including a $22 million follow-on order. AI data center business now contributes approximately 71% of annual revenue, marking a significant structural transformation from its prior reliance on silicon carbide for EVs.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)